{"id":"NCT00065507","sponsor":"Bristol-Myers Squibb","briefTitle":"Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation","officialTitle":"Comparison of the Efficacy and Safety of Entecavir Versus Adefovir in Subjects Chronically Infected With Hepatitis B Virus and Evidence of Hepatic Decompensation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-08","primaryCompletion":"2008-10","completion":"2013-05","firstPosted":"2003-07-29","resultsPosted":"2010-07-02","lastUpdate":"2013-06-24"},"enrollment":195,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis B"],"interventions":[{"type":"DRUG","name":"Entecavir (ETV)","otherNames":["Baraclude","BMS-200475"]},{"type":"DRUG","name":"Adefovir (ADV)","otherNames":[]}],"arms":[{"label":"A1","type":"EXPERIMENTAL"},{"label":"A2","type":"ACTIVE_COMPARATOR"}],"summary":"This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) vs. adefovir 10 mg QD in patients who have chronic hepatitis B infection and hepatic decompensation. The patients are treated for 96 weeks after the last subject is randomized.","primaryOutcome":{"measure":"Change From Baseline in Hepatitis B Virus (HBV) DNA by Polymerase Chain Reaction (PCR) at Week 24","timeFrame":"Baseline, Week 24","effectByArm":[{"arm":"Entecavir (ETV) 1.0 mg","deltaMin":-4.48,"sd":0.2},{"arm":"Adefovir (ADV) 10 mg","deltaMin":-3.4,"sd":0.255}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":61,"countries":["United States","Brazil","Canada","France","Greece","Hong Kong","India","Indonesia","Philippines","Poland","Russia","Singapore","South Africa","Taiwan","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":59,"n":89},"commonTop":["OEDEMA PERIPHERAL","PYREXIA","DIARRHOEA","UPPER RESPIRATORY TRACT INFECTION","COUGH"]}}